Lilotomab
id:
lilotomab-270-6434906
title:
Lilotomab
text:
Lilotomab is a murine monoclonal antibody against CD37, a glycoprotein which is expressed on the surface of mature human B cells. It was generated at the Norwegian Radium Hospital. As of 2016 it was under development by the Norwegian company Nordic Nanovector ASA as a radioimmunotherapeutic in which lilotomab is conjugated to the beta radiation-emitting isotope lutetium-177 by means of a linker called satetraxetan, a derivative of DOTA. This compound is called 177Lu-HH1 or lutetium (177Lu) lilot
brand slug:
wiki
category slug:
encyclopedia
description:
Murine monoclonal antibody against CD37
original url:
https://en.wikipedia.org/wiki/Lilotomab
date created:
date modified:
2023-09-04T21:38:56Z
main entity:
{"identifier":"Q17131070","url":"https://www.wikidata.org/entity/Q17131070"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/d/dc/Lutetium-177_satetraxetan.svg","width":604,"height":363}
fields total:
13
integrity:
15